A new trading day began on Friday, with Tango Therapeutics Inc (NASDAQ: TNGX) stock price up 12.70% from the previous day of trading, before settling in for the closing price of $8.9. TNGX’s price has ranged from $1.03 to $9.70 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 7.47% over the past five years. Meanwhile, its annual earnings per share averaged 26.61%. With a float of $86.79 million, this company’s outstanding shares have now reached $111.57 million.
Tango Therapeutics Inc (TNGX) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Tango Therapeutics Inc is 41.13%, while institutional ownership is 72.60%. The most recent insider transaction that took place on Oct 23 ’25, was worth 4,846,575. In this transaction 10% Owner of this company sold 477,401 shares at a rate of $10.15, taking the stock ownership to the 13,386,574 shares. Before that another transaction happened on Oct 23 ’25, when Company’s 10% Owner proposed sale 477,401 for $7.53, making the entire transaction worth $3,594,830.
Tango Therapeutics Inc (TNGX) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.34 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.29 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.61% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -5.06% during the next five years compared to 7.47% growth over the previous five years of trading.
Tango Therapeutics Inc (NASDAQ: TNGX) Trading Performance Indicators
Here are Tango Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.88. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 20.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.92, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -1.24 in one year’s time.
Technical Analysis of Tango Therapeutics Inc (TNGX)
Tango Therapeutics Inc (NASDAQ: TNGX) saw its 5-day average volume 3.41 million, a positive change from its year-to-date volume of 2.12 million. As of the previous 9 days, the stock’s Stochastic %D was 84.83%.
During the past 100 days, Tango Therapeutics Inc’s (TNGX) raw stochastic average was set at 99.15%, which indicates a significant increase from 98.52% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.73 in the past 14 days, which was higher than the 0.56 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.03, while its 200-day Moving Average is $4.85. Nevertheless, the first resistance level for the watch stands at $10.56 in the near term. At $11.08, the stock is likely to face the second major resistance level. The third major resistance level sits at $12.10. If the price goes on to break the first support level at $9.02, it is likely to go to the next support level at $8.00. Assuming the price breaks the second support level, the third support level stands at $7.48.
Tango Therapeutics Inc (NASDAQ: TNGX) Key Stats
With a market capitalization of 1.35 billion, the company has a total of 134,594K Shares Outstanding. Currently, annual sales are 42,070 K while annual income is -130,300 K. The company’s previous quarter sales were 53,810 K while its latest quarter income was 15,880 K.
